TTAB Oppositions 91217661
USPTO Oppositions proceeding 91217661, filed 2014-07-31. Status: Terminated.
Proceeding Facts
| Proceeding Number | 91217661 |
|---|---|
| Type | Oppositions |
| Status | Terminated |
| Filing Date | 2014-07-31 |
| Last Activity | 2015-01-20 |
| Days Active | 4305 |
Parties
- Actavis, Inc. — Defendant
- Genentech, Inc. — Plaintiff
Plaintiff Marks
- ACTIVASE — Genentech, Inc.
- ACTIVASE ALTEPLASE A RECOMBINANT TISSUE PLASMINOGEN ACTIVATOR THE ONE T-PA FOR STROKE — Genentech, Inc.
- CATHFLO ACTIVASE (ALTEPLASE) THE ONE 2-MG T-PA — Genentech, Inc.
Defendant Marks
- ACTAVIS PHARMA — Actavis, Inc.
Recent Documents
- 2015-01-20: TERMINATED — Status
- 2015-01-06: BD DECISION: DISMISSED W/O PREJ — Decisions
- 2014-12-11: DEF'S AMENDMENT — Miscellaneous
- 2014-12-03: EXTENSION OF TIME GRANTED — Extensions
- 2014-12-03: STIP FOR EXT — Extensions
- 2014-09-03: SUSPENDED — Status
- 2014-09-03: STIP TO SUSP PEND SETTL NEGOTIATIONS — Motions
- 2014-07-31: PENDING, INSTITUTED — Status
- 2014-07-31: NOTICE AND TRIAL DATES SENT; ANSWER DUE: — Scheduling
- 2014-07-31: FILED AND FEE — Fees